SEVORANE Side Effects

6804527-4 | Hypotension, Nausea, Supraventricular Extrasystoles
on Jun 18, 2010 Female patient from THAILAND , weighting 121.3 lb, was treated with Sevorane (View Usage). Patient experienced the following unwanted or unexpected effects: hypotension, nausea (What is nausea?), supraventricular extrasystoles. Sevorane dosage: Range 1-2%. During the same period patient was treated with SUCCINYLCHOLINE (View Succinylcholine Review and Succinylcholine Label ), PAVULON (View Pavulon Review and Pavulon Label ), MORPHINE (View Morphine Review and Morphine Label ), O2:N20 (View O2:n20 Review and O2:n20 Label ).

6772928-9 | Cardio-respiratory Arrest
Patient was taking Sevorane (View Usage). Patient had the following side effects: cardio-respiratory arrest on Jun 10, 2010 from SPAIN Additional patient health information: Male patient , child 2 years of age, was diagnosed with induction of anaesthesia, prophylaxis against gastrointestinal ulcer, pulmonary hypertension (What is pulmonary hypertension?) and. Sevorane dosage: . During the same period patient was treated with RANITIDINA (View Ranitidina Review and Ranitidina Label ), CEFAZOLINA (View Cefazolina Review and Cefazolina Label ), VANCOMICINA (View Vancomicina Review and Vancomicina Label ), SILDENAFILO (View Sildenafilo Review and Sildenafilo Label ), CEFOTAXIMA (View Cefotaxima Review and Cefotaxima Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), SEGURIL (View Seguril Review and Seguril Label ). Patient was hospitalized.

6673620-1 | Atrial Fibrillation, Cardiac Failure, Cardio-respiratory Arrest, Ejection Fraction Decreased, Hypoxia
Adverse event was reported on Mar 29, 2010 by a Female patient taking Sevorane (View Usage) (Dosage: 1 Dosage From, Once) was diagnosed with anaesthesia and. Location: FRANCE , 28 years of age, After Sevorane was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), cardiac failure, cardio-respiratory arrest, ejection fraction decreased, hypoxia. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), DOPRAM (View Dopram Review and Dopram Label ). Patient was hospitalized.

6490200-1 | Anaphylactic Reaction, Flushing, Pruritus, Respiratory Disorder, Urticaria, Wheezing
on Dec 03, 2009 Female patient from GERMANY , weighting 132.3 lb, was treated with Sevorane (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, flushing, pruritus, respiratory disorder, urticaria, wheezing. Sevorane dosage: .


5860137-7 | Hypotension, Nausea, Supraventricular Extrasystoles
on Aug 19, 2008 Female patient from THAILAND , weighting 121.3 lb, was treated with Sevorane (View Usage). Patient had the following side effects: hypotension, nausea (What is nausea?), supraventricular extrasystoles. Sevorane dosage: Range 1-2%. During the same period patient was treated with SUXAMETHONIUM CHLORIDE (View Suxamethonium Chloride Review and Suxamethonium Chloride Label ), PAVOLON (View Pavolon Review and Pavolon Label ), MORPHINE (View Morphine Review and Morphine Label ).

5789000-7 | Renal Failure Acute
Patient was taking Sevorane (View Usage). After Sevorane was administered, patient had the following side effects: renal failure acute on Jun 19, 2008 from FRANCE Additional patient health information: Male patient , weighting 4.65 lb, was diagnosed with anaesthesia, hypertension, vitamin supplementation, mineral supplementation and. Sevorane dosage: . During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), RETINOL (View Retinol Review and Retinol Label ), FUMARATE FERROUS (View Fumarate Ferrous Review and Fumarate Ferrous Label ), ERGOCALCIFEROL (View Ergocalciferol Review and Ergocalciferol Label ), TOCOPHERYL ACETATE (View Tocopheryl Acetate Review and Tocopheryl Acetate Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ). Patient was hospitalized.

5752922-7 | Asthenia, Myoclonus
Adverse event was reported on May 22, 2008 by a Female patient taking Sevorane (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: AUSTRALIA , weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: asthenia, myoclonus. During the same period patient was treated with FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), PROPOFOL (View Propofol Review and Propofol Label ). Patient was hospitalized.

5751320-X | Hemiparesis, Migraine With Aura, Sensory Loss
on May 22, 2008 Male patient from AUSTRALIA , 15 years of age, weighting 152.1 lb, was diagnosed with sensory disturbance and was treated with Sevorane (View Usage). Patient had the following side effects: hemiparesis, migraine with aura, sensory loss. Sevorane dosage: . During the same period patient was treated with FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), NITROUS OXIDE (View Nitrous Oxide Review and Nitrous Oxide Label ), PROPOFOL (View Propofol Review and Propofol Label ), MORPHINE NOS (Not Reported) (View Morphine Nos Review and Morphine Nos Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PARECOXIB SODIUM (Not Reported) (View Parecoxib Sodium Review and Parecoxib Sodium Label ). Patient was hospitalized.

5614421-2 | Priapism
on Jan 28, 2008 Male patient from SPAIN , 39 years of age, was diagnosed with surgery (What is surgery?) and was treated with Sevorane (View Usage). After Sevorane was administered, patient had the following side effects: priapism. Sevorane dosage: . During the same period patient was treated with NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ), NIMBEX (View Nimbex Review and Nimbex Label ), PROPOFOL (1 %) (View Propofol Review and Propofol Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ANECTINE (View Anectine Review and Anectine Label ).

5602953-2 | Priapism
Patient was taking Sevorane (View Usage). Patient experienced the following unwanted or unexpected effects: priapism on Jan 18, 2008 from SPAIN Additional patient health information: Male patient , 39 years of age, was diagnosed with surgery (What is surgery?) and. Sevorane dosage: . During the same period patient was treated with NITRAZEPAM (View Nitrazepam Review and Nitrazepam Label ), NIMBEX (View Nimbex Review and Nimbex Label ), PROPOFOL (1 %) (View Propofol Review and Propofol Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ANECTINE AMP (View Anectine Amp Review and Anectine Amp Label ).

5600745-1 | Agitation, Muscle Rigidity
Adverse event was reported on Jan 15, 2008 by a Male patient taking Sevorane (View Usage) (Dosage: ) was diagnosed with induction of anaesthesia, maintenance of anaesthesia and. Location: ISRAEL , child 2 years of age, weighting 22.05 lb, Patient had the following side effects: agitation, muscle rigidity. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), MORPHINE (View Morphine Review and Morphine Label ).

5399750-2 | Blood Urea, Creatinine Renal Clearance Increased, Renal Failure Acute
on Jul 18, 2007 Female patient from ITALY , 48 years of age, was treated with Sevorane (View Usage). After Sevorane was administered, patient had the following side effects: blood urea, creatinine renal clearance increased, renal failure acute. Sevorane dosage: . During the same period patient was treated with ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), NADROPARINE (View Nadroparine Review and Nadroparine Label ). Patient was hospitalized.

5351915-1 | Blood Urea, Creatinine Renal Clearance Increased, Renal Failure Acute
on May 31, 2007 Female patient from ITALY , 48 years of age, was treated with Sevorane (View Usage). Patient experienced the following unwanted or unexpected effects: blood urea, creatinine renal clearance increased, renal failure acute. Sevorane dosage: . During the same period patient was treated with ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), CEFAZOLIN (View Cefazolin Review and Cefazolin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), KETOROLAC TROMETHAMINE (View Ketorolac Tromethamine Review and Ketorolac Tromethamine Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), NADROPARINE (View Nadroparine Review and Nadroparine Label ). Patient was hospitalized.

5223385-5 | Candida Sepsis, Laryngeal Oedema, Mydriasis, Respiratory Arrest, Respiratory Disorder, Respiratory Distress
Patient was taking Sevorane (View Usage). Patient had the following side effects: candida sepsis, laryngeal oedema, mydriasis, respiratory arrest, respiratory disorder, respiratory distress on Jan 19, 2007 from FRANCE Additional patient health information: Male patient , 65 years of age, was diagnosed with anaesthesia, renal disorder and. Sevorane dosage: . During the same period patient was treated with FACTOR I (FIBRINOGEN) (View Factor I (fibrinogen) Review and Factor I (fibrinogen) Label ), NIMBEX (View Nimbex Review and Nimbex Label ), PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), THROMBIN LOCAL SOLUTION (View Thrombin Local Solution Review and Thrombin Local Solution Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PIRITRAMIDE (View Piritramide Review and Piritramide Label ). Patient was hospitalized.

5112561-8 | Hyperthermia Malignant
Adverse event was reported on Jul 27, 2006 by a Male patient taking Sevorane (View Usage) (Dosage: Total Daily Dose: Cam 2) was diagnosed with anaesthesia, hypotonia, analgesic effect and. Location: VENEZUELA , 30 years of age, weighting 308.6 lb, After Sevorane was administered, patient had the following side effects: hyperthermia malignant. During the same period patient was treated with PENTHOTAL (View Penthotal Review and Penthotal Label ), SUXAMETHONIUM CHLORIDE (View Suxamethonium Chloride Review and Suxamethonium Chloride Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ).

5071942-1 | Laryngeal Oedema, Mydriasis, Respiratory Arrest, Respiratory Disorder, Respiratory Distress
on Jul 27, 2006 Male patient from FRANCE , 65 years of age, was diagnosed with anaesthesia, renal disorder and was treated with Sevorane (View Usage). Patient experienced the following unwanted or unexpected effects: laryngeal oedema, mydriasis, respiratory arrest, respiratory disorder, respiratory distress. Sevorane dosage: . During the same period patient was treated with FACTOR I (FIBRINOGEN) (View Factor I (fibrinogen) Review and Factor I (fibrinogen) Label ), NIMBEX (View Nimbex Review and Nimbex Label ), PROPOFOL (View Propofol Review and Propofol Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), THROMBIN (View Thrombin Review and Thrombin Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), PIRITRAMIDE (View Piritramide Review and Piritramide Label ). Patient was hospitalized.

5070481-1 | Hyperthermia Malignant
on Jul 27, 2006 Male patient from VENEZUELA , 30 years of age, weighting 308.6 lb, was diagnosed with anaesthesia, hypotonia, analgesic effect and was treated with Sevorane (View Usage). Patient had the following side effects: hyperthermia malignant. Sevorane dosage: Total Daily Dose: Cam 2. During the same period patient was treated with PENTHOTAL (View Penthotal Review and Penthotal Label ), SUXAMETHONIUM CHLORIDE (View Suxamethonium Chloride Review and Suxamethonium Chloride Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ).

5033911-7 | Cough, Haemoptysis
Patient was taking Sevorane (View Usage). After Sevorane was administered, patient had the following side effects: cough, haemoptysis on Jun 14, 2006 from ARGENTINA Additional patient health information: Male patient , 16 years of age, was diagnosed with anaesthesia and. Sevorane dosage: . Patient was hospitalized.

4947334-X | Anaemia, Asthenia, Mucosal Discolouration, Oedema Peripheral, Pallor, Pruritus, Rash, Urticaria, Weight Decreased
Adverse event was reported on Feb 23, 2006 by a Male patient taking Sevorane (View Usage) (Dosage: ) was diagnosed with anaesthesia and. Location: FRANCE , 69 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: anaemia, asthenia, mucosal discolouration, oedema peripheral, pallor, pruritus, rash (What is rash?), urticaria, weight decreased. During the same period patient was treated with KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), CEFUROXIME AXETIL (View Cefuroxime Axetil Review and Cefuroxime Axetil Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ), PROPOFOL (View Propofol Review and Propofol Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), PHLOROGLUCINOL (View Phloroglucinol Review and Phloroglucinol Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

4932361-9 | Anaemia, Asthenia, Mucosal Discolouration, Oedema Peripheral, Pallor, Pruritus, Rash, Urticaria, Weight Decreased
on Feb 23, 2006 Male patient from FRANCE , 69 years of age, weighting 176.4 lb, was diagnosed with anaesthesia and was treated with Sevorane (View Usage). Patient had the following side effects: anaemia, asthenia, mucosal discolouration, oedema peripheral, pallor, pruritus, rash (What is rash?), urticaria, weight decreased. Sevorane dosage: . During the same period patient was treated with KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), CEFUROXIME AXETIL (View Cefuroxime Axetil Review and Cefuroxime Axetil Label ), SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ), PROPOFOL (View Propofol Review and Propofol Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), PHLOROGLUCINOL (View Phloroglucinol Review and Phloroglucinol Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

4791939-6 | Cardiac Arrest
on Sep 27, 2005 Female patient from RUSSIAN FEDERATION , child 1. years of age, was diagnosed with anaesthesia and was treated with Sevorane (View Usage). After Sevorane was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?). Sevorane dosage: Not Reported.